
Heritage Group
Description
Heritage Group, based in Nashville, Tennessee, is a distinguished venture capital firm with a specialized focus on the healthcare sector. Established in 1986, the firm has built a robust reputation for investing in rapidly growing companies that aim to enhance the affordability, accessibility, and quality of care. Their long-standing presence in the industry, spanning over three decades, underscores their deep expertise and extensive network within healthcare, making them a significant player in the health innovation ecosystem.
Heritage Group primarily targets growth equity and venture capital opportunities within healthcare services and healthcare technology. The firm typically deploys initial investments ranging from $20 million to $40 million in growth equity rounds, aiming to support companies with proven business models ready for significant scaling. Beyond capital, Heritage Group leverages its unique network of 15 leading healthcare systems and organizations, providing portfolio companies with unparalleled strategic insights, operational guidance, and access to potential customers and partners.
With a track record of investing over $1.5 billion across more than 50 healthcare companies since its inception, Heritage Group demonstrates a commitment to long-term partnerships. The firm recently closed its Heritage Healthcare Innovation Fund II in 2021, securing $300 million to continue its investment strategy. While their primary focus is on growth-stage companies, they also participate in earlier-stage venture rounds, where their initial investment may be smaller, reflecting a flexible approach to supporting innovation across the healthcare continuum. Their strategic approach emphasizes not just financial returns but also the transformative impact on the healthcare landscape.
Investor Profile
Heritage Group has backed more than 54 startups, with 4 new investments in the last 12 months alone. The firm has led 21 rounds, about 39% of its total and boasts 17 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Health Care, Software, Information Technology.
- Led 3 rounds in the past year.
- Typical check size: $20M – $40M.
Stage Focus
- Series Unknown (39%)
- Series B (19%)
- Series C (15%)
- Series A (9%)
- Corporate Round (6%)
- Pre Seed (4%)
- Series E (2%)
- Seed (2%)
- Series D (2%)
- Debt Financing (2%)
Country Focus
- United States (98%)
- Israel (2%)
Industry Focus
- Health Care
- Software
- Information Technology
- Medical
- Hospital
- Wellness
- Enterprise Software
- Biotechnology
- Pharmaceutical
- Medical Device
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.